Sanket Koul
Sanket Koul
Move to give relief to thousands of homebuyers and developers
Mankind Pharma has entered a licensing agreement with Actimed Therapeutics to develop and commercialise cachexia treatment products across India and neighbouring South Asian markets
The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and India's drug-resistant infection rates are still relatively low
CSIR-IGIB and Serum Institute of India have partnered to transfer indigenous CRISPR-based technology that could cut sickle cell gene therapy costs from crores to a fraction
Innovation fund for deep tech collabs, setting up of labs and 100% deduction on capex under section 35 AD of IT Act among key demands
India's high-street retail markets recorded steady rent growth in 2025, driven by premiumisation, limited supply and strong demand in major cities, Cushman & Wakefield said
The new plan attempts to plug gaps identified during the implementation of the first NAP-AMR (2017-21)
NBCC sold selling rights for 609 units in Amrapali's Aspire Leisure Valley and Centurion Park to AU Real Estate to raise funds for completing stalled housing projects
The NPPA has extended the knee implant price cap despite industry requests to remove or relax it, citing rising costs and innovation needs, as the regulator prioritises affordability for patients
A 7-member AIMED delegation explored regulatory alignment, market access and technology-sharing opportunities in the UK as India targets a sharp rise in medical device exports by 2030
The launch comes five months after YEIDA had warned the developer of cancelling its allotment for a 100-acre Greenbay Golf Village over failure to deposit outstanding dues at the time
This would unlock export potential of $6 billion for Indian pharma companies
Realty developer Anant Raj has signed an MoU with the Andhra Pradesh government to invest Rs 4,500 crore in a data and cloud services centre, a move expected to create nearly 16,000 jobs
Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37% to improve accessibility and expand its market in India
Despite this, the CDMO segment remained Akums' key growth driver, contributing Rs 804 crore, or 79 per cent of its total revenue
India sales grew 14% Y-o-Y to ₹2,766 crore in the September quarter, while international sales rose 29.5% to ₹1,189 crore, contributing 31.7% to overall revenue
Key micro-markets saw an increase in leasing activity, with e-commerce and 3PL players gaining momentum
India made strong gains in TB reduction, cutting incidence by 21% since 2015, but still accounted for 25% of global cases in 2024, according to the WHO's Global TB Report 2025
The Union Health Ministry held consultations to strengthen nursing education and governance, focusing on reforms, skill enhancement and equitable workforce distribution across India
The Centre has asked all states and UTs to open chest clinics under the National Programme on Climate Change and Human Health to tackle pollution-related illnesses during peak smog months